Sutro Biopharma Inc. (STRO)
NASDAQ: STRO
· Real-Time Price · USD
0.92
0.04 (4.78%)
At close: Aug 18, 2025, 3:59 PM
0.88
-4.32%
After-hours: Aug 18, 2025, 05:53 PM EDT
Sutro Biopharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 64.03M | 106.23M | 190.3M | 174.58M | 90.79M | 65.22M | 69.27M | 81.83M | 235.09M | 251.47M | 47.25M | 96.78M | 79.11M | 28.9M | 30.41M | 30.71M | 56.39M | 55.82M |
Short-Term Investments | 141.11M | 142.74M | 126.59M | 213.68M | 335.2M | 248M | 306.35M | 273.32M | 156.55M | 25.03M | 287.11M | 227.47M | 146.52M | 180.24M | 167.52M | 198.99M | 202.31M | 195.41M |
Long-Term Investments | 858K | n/a | n/a | n/a | n/a | 857K | n/a | -34.04M | -33.35M | 163.97M | -32.02M | n/a | n/a | 20.7M | 68.78M | 64.28M | 60.01M | 74.61M |
Other Long-Term Assets | 50K | 943K | 8.03M | 8.03M | 5.82M | 5.74M | 4.44M | 38.18M | 37.49M | -142.15M | 34.75M | 2.79M | 2.79M | 2.58M | 2.53M | 3.02M | 3.5M | 3.08M |
Receivables | 8M | 13.56M | 8.62M | 6.66M | 6.95M | 31.3M | 36.08M | 16.63M | 10M | 9.87M | 7.12M | 11.24M | 97.67M | 11.69M | 12.45M | 12.33M | 9.16M | 7.23M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -17.7M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 18.5M | 24.88M | 17.8M | 10.87M | 10.53M | 10.06M | 9.85M | 9.48M | 10.34M | 17.7M | 11.67M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 231.63M | 287.41M | 343.31M | 405.78M | 443.48M | 354.58M | 421.54M | 381.25M | 411.99M | 286.37M | 353.15M | 346.55M | 331.51M | 228.74M | 218.51M | 250.73M | 277.62M | 266M |
Property-Plant & Equipment | 29.82M | 33.08M | 35.87M | 38.02M | 39.75M | 42.22M | 44.76M | 46.34M | 48.77M | 49.83M | 51.06M | 51.35M | 51.32M | 51.66M | 51.59M | 53.45M | 18.67M | 14.83M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 30.73M | 34.02M | 43.9M | 46.05M | 45.57M | 48.82M | 49.19M | 50.48M | 52.91M | 71.65M | 53.79M | 54.15M | 54.11M | 74.93M | 122.89M | 120.74M | 82.17M | 92.53M |
Total Assets | 262.36M | 321.43M | 387.21M | 451.83M | 489.04M | 403.4M | 470.74M | 431.73M | 464.9M | 358.02M | 406.94M | 400.7M | 385.62M | 303.68M | 341.41M | 371.47M | 359.79M | 358.53M |
Account Payables | 4.31M | 8.18M | 10.47M | 6.22M | 6.09M | 7.51M | 9.44M | 5.53M | 3.86M | 5.06M | 4.8M | 12.44M | 12.57M | 10.71M | 6.01M | 11.17M | 7.64M | 5.89M |
Deferred Revenue | 11.96M | 68.98M | 69.78M | 72.56M | 73.96M | 20.5M | 20.67M | 23.98M | 18.04M | 102.23M | 16.76M | 15.92M | 6.49M | 6.28M | 5.5M | 7.8M | 8.13M | 12.09M |
Short-Term Debt | 8.06M | n/a | n/a | n/a | n/a | 6.67M | 4.06M | 7.14M | 16.13M | 18.49M | 17.09M | 15.13M | 13.62M | 13.58M | 10.41M | 7.7M | 3.13M | n/a |
Other Current Liabilities | 38.15M | 25.73M | 16.91M | 32.12M | 33.05M | 15.91M | 38.47M | 19.42M | 13.66M | 7.14M | 11.64M | 12.16M | 10.78M | 7.12M | 10.38M | 7.34M | 7.23M | 185K |
Total Current Liabilities | 74.25M | 133.05M | 131.89M | 131.29M | 129.99M | 79.51M | 93.75M | 73.61M | 67.13M | 126.04M | 66.55M | 58.29M | 44.57M | 38.76M | 41.74M | 35.45M | 26.13M | 22.66M |
Long-Term Debt | 11.54M | n/a | 180.81M | 171.97M | n/a | 156.47M | 149.11M | n/a | n/a | n/a | 3.77M | 6.78M | 9.78M | 12.76M | 15.74M | 18.71M | 21.69M | 24.68M |
Other Long-Term Liabilities | 208.68M | 1.69M | 1.69M | 1.69M | 1.69M | 1.69M | 1.69M | 142.76M | 136.65M | n/a | 119K | 133K | 142K | 147K | 146K | 1.5M | 4.28M | 3.03M |
Total Long-Term Liabilities | 220.22M | 214.19M | 210.71M | 209.32M | 206.88M | 225.87M | 227.34M | 245.78M | 243.06M | 46.56M | 123.35M | 112.69M | 131.99M | 44.54M | 47.11M | 52.44M | 26.16M | 28.53M |
Total Liabilities | 294.47M | 347.24M | 342.61M | 340.61M | 336.87M | 305.38M | 321.09M | 319.39M | 310.18M | 172.6M | 189.9M | 170.97M | 176.56M | 83.3M | 88.84M | 87.89M | 52.29M | 51.19M |
Total Debt | 19.59M | 21.4M | 23.15M | 24.86M | 26.53M | 184.53M | 33.63M | 38.17M | 42.66M | 46.56M | 50.43M | 52.95M | 55.47M | 57.97M | 57.37M | 58.48M | 24.82M | 24.68M |
Common Stock | 85K | 84K | 83K | 82K | 82K | 62K | 61K | 61K | 60K | 60K | 58K | 55K | 49K | 47K | 46K | 46K | 46K | 46K |
Retained Earnings | -874.34M | -862.84M | -786.87M | -714.43M | -665.64M | -617.62M | -559.41M | -590.47M | -541.19M | -502.67M | -452.62M | -418.02M | -398.53M | -372.52M | -333.41M | -295.29M | -264.38M | -258.23M |
Comprehensive Income | -13K | -9K | 39K | 106K | -163K | -113K | 21K | 7K | 16K | -107K | -618K | -1.34M | -1.36M | -1.15M | -314K | -30K | -45K | 0.00 |
Shareholders Equity | -32.11M | -25.81M | 44.6M | 111.22M | 152.18M | 98.02M | 149.65M | 112.35M | 154.72M | 185.41M | 217.05M | 229.73M | 209.06M | 220.37M | 252.56M | 283.58M | 307.5M | 307.34M |
Total Investments | 141.96M | 142.74M | 126.59M | 213.68M | 335.2M | 248.86M | 306.35M | 239.27M | 123.2M | 188.99M | 255.09M | 227.47M | 146.52M | 200.94M | 199.12M | 263.27M | 262.32M | 270.02M |